These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 6419367

  • 1. [Plasmapheresis in the treatment of paraproteinemic hemoblastoses].
    Ryzhko VV, Gorodetskiĭ VM.
    Ter Arkh; 1983; 55(11):70-5. PubMed ID: 6419367
    [No Abstract] [Full Text] [Related]

  • 2. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
    Abdullaev OM, Postnikov AA, Prigozhina TA, Likhovetskaia ZM, Mokeeva RA.
    Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
    [Abstract] [Full Text] [Related]

  • 3. [Paraproteinemic hemoblastosis].
    Rybakova ME.
    Med Sestra; 1977 Aug; 36(8):37-40. PubMed ID: 414047
    [No Abstract] [Full Text] [Related]

  • 4. [The monitoring of protein-volemic indices during plasmapheresis in patients with paraproteinemic hemoblastoses].
    Kalinin NN, Movshev BE, Petrov MM, Petrova VI, Droshneva VA, Varlamova SV, Khoroshko ND, Zhuravlev VS, Loginov SP.
    Ter Arkh; 1996 Aug; 68(7):62-5. PubMed ID: 8928075
    [Abstract] [Full Text] [Related]

  • 5. [Clinical study on the effect of human lymphoblastoid interferon in B-cell malignancies].
    Takeyama H, Yano K, Kataoka T, Watanabe E, Kobayashi M, Ohno R.
    Rinsho Ketsueki; 1984 Dec; 25(12):1921-7. PubMed ID: 6442741
    [No Abstract] [Full Text] [Related]

  • 6. [Reestablishment of plasma proteins after plasmapheresis in patients with paraproteinemic hemoblastosis].
    Movshev BE, Kalinin NN, Petrov MM, Petrova VI.
    Ter Arkh; 1999 Dec; 71(10):40-3. PubMed ID: 10612173
    [Abstract] [Full Text] [Related]

  • 7. [Use of plasmapheresis in surgical hematology].
    Abdulkadyrov KM, Shatrov VA, Katsadze IuL.
    Vestn Khir Im I I Grek; 1983 Oct; 131(10):125-8. PubMed ID: 6419431
    [Abstract] [Full Text] [Related]

  • 8. [Rare forms of paraproteinemic hemoblastosis].
    Andreeva NE.
    Ter Arkh; 1984 Oct; 56(6):59-63. PubMed ID: 6433500
    [Abstract] [Full Text] [Related]

  • 9. [Plasmapheresis and hyperviscosity syndrome].
    Corral Alonso M, Barbolla ML.
    Sangre (Barc); 1984 Oct; 29(5):940-50. PubMed ID: 6441295
    [No Abstract] [Full Text] [Related]

  • 10. Current views on immunoglobulin abnormalities and B cell proliferations.
    Seligmann M, Clauvel JP.
    Adv Nephrol Necker Hosp; 1977 Oct; 7():237-59. PubMed ID: 96675
    [No Abstract] [Full Text] [Related]

  • 11. Clinical utilization of plasmapheresis and cyclophosphamide in the treatment of malignant lymphoproliferative processes.
    Sakalová A, Gazová S, Hrubisko M, Gáliková J.
    Neoplasma; 1973 Oct; 20(3):335-9. PubMed ID: 4199115
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA, Zhuravlev VS.
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract] [Full Text] [Related]

  • 13. [Extracorporeal methods of therapy in lymphatic tumors].
    Ryzhko VV, Andreeva NE, Gorodetskiĭ VM, Konovalova VI, Aleksanian MZh, Sinitsina TV.
    Ter Arkh; 1990 Mar; 62(7):59-63. PubMed ID: 2123573
    [Abstract] [Full Text] [Related]

  • 14. Removal and recovery rate of paraproteins by plasma exchange.
    Busnach G, Perrino ML, Dal Col A, Brando B, Minetti L.
    Life Support Syst; 1983 Mar; 1 Suppl 1():112-4. PubMed ID: 6443836
    [No Abstract] [Full Text] [Related]

  • 15. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
    Amamiya Y, Baba M, Hisamitsu J, Ito T, Amaki T.
    Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
    [No Abstract] [Full Text] [Related]

  • 16. [Therapeutic plasmapheresis--a new form of adjuvant treatment (author's transl)].
    Tilz GP, Teubl I, Kopplhuber C, Vollmann H, Lanzer G.
    Med Klin; 1976 Nov 05; 71(45):1952-7. PubMed ID: 825711
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
    Kaplan AA.
    Ther Apher; 2001 Jun 05; 5(3):171-5. PubMed ID: 11467752
    [Abstract] [Full Text] [Related]

  • 18. [Atypical paraproteinemic hemoblastoses (author's transl)].
    Rentsch I, Gärtner U, Stocker W.
    MMW Munch Med Wochenschr; 1978 Nov 24; 120(47):1567-70. PubMed ID: 102955
    [Abstract] [Full Text] [Related]

  • 19. [Multiple myeloma and other plasma cell dyscrasias].
    del Potro Gómez E, Morales Sanz D.
    Rev Clin Esp; 1999 Apr 24; 199 Suppl 1():52-7. PubMed ID: 10422451
    [No Abstract] [Full Text] [Related]

  • 20. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.
    Mód A, Füst G, Harsányi V, Natonek K, Poros A, Szabó J, Hollán SR.
    Haematologia (Budap); 1981 Apr 24; 14(1):49-56. PubMed ID: 6454615
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.